Structural Biology

Edited by : Neeraja Sankaran Y. Cho, S. Gorina, P.D. Jeffrey, N.P. Pavletich, "Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations," Science, 265:346-55, 1994. (Cited in more than 140 publications through November 1995) Comments by Nikola Pavletich, Memorial Sloan-Kettering Cancer Center, New York City "One of the goals in cancer biology has been to find a unifying theme underlying the cause of cancer, and the p53 tumor suppressor is the closest we hav

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by : Neeraja Sankaran

Y. Cho, S. Gorina, P.D. Jeffrey, N.P. Pavletich, "Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations," Science, 265:346-55, 1994. (Cited in more than 140 publications through November 1995)

Comments by Nikola Pavletich, Memorial Sloan-Kettering Cancer Center, New York City

"One of the goals in cancer biology has been to find a unifying theme underlying the cause of cancer, and the p53 tumor suppressor is the closest we have come to that," declares Nikola Pavletich, an assistant member in the cellular biochemistry and biophysics program at Memorial Sloan-Kettering Cancer Center in New York.

"Because it is the most frequently mutated gene to be identified in triggering many different human cancers, p53 has been the focus of intense research. This paper is the first description of the three-dimensional atomic structure of p53 bound to a DNA molecule," he adds, proposing this as the main ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies